Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2026-03-02 @ 3:45 PM
Study NCT ID:
NCT01910402
Status:
COMPLETED
Last Update Posted:
2024-02-20
First Post:
2013-07-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
Sponsor:
ViiV Healthcare
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08-22
Start Date Type:
ACTUAL
Primary Completion Date:
2015-09-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-18
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-25
First Submit QC Date:
None
Study First Post Date:
2013-07-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-07-25
Results First Submit QC Date:
None
Results First Post Date:
2016-10-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-14
Last Update Post Date:
2024-02-20
Last Update Post Date Type:
ACTUAL